z-logo
open-access-imgOpen Access
Treating Agitation in Patients with Dementia with a Therapy Dog in a Milieu Therapy Setting on a Geropsychiatric Ward
Author(s) -
Jana Krüger,
Reyhan Izgi,
Rainer Hellweg,
Andreas Ströhle,
Maria C. Jockers-Scherübl
Publication year - 2021
Publication title -
dementia and geriatric cognitive disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.026
H-Index - 110
eISSN - 1421-9824
pISSN - 1420-8008
DOI - 10.1159/000520881
Subject(s) - dementia , psychology , psychomotor agitation , psychiatry , medicine , disease
Background: Animal-assisted intervention has become a common therapeutic practice used for patients with dementia in home-dwelling and institutions. The most established procedure is a visiting service by specially trained dogs and their owners to improve social interactions and reduce symptoms of agitation. Objectives: The study aims to investigate the effects of a therapy dog on agitation of inpatients with dementia in a gerontopsychiatric ward. Materials and Methods: The severity of agitation was assessed by a rater blinded for the presence of the dog via the Overt Agitation Severity Scale (OASS). The scale was conducted on 1 day with the dog and his handler present (resident doctor on the ward) and on another day with only the handler present. Each patient was his/her own control. Heart rate variability (HRV) and serum level of brain-derived neurotrophic factor (BDNF) of the patients were measured on both days. 26 patients with the Mini-Mental Status Examination (MMSE) score <21 and the diagnosis of dementia were included in the study. Results: A significant reduction of agitation in the OASS could be shown when the dog was present ( p = 0.006). The data neither demonstrated a difference in the HRV for the parameters mean heart rate ( p = 0.65), root mean square of successive differences ( p = 0.63), and high frequencies ( p = 0.27) nor in serum BDNF concentrations ( p = 0.42). Discussion: Therapy dogs can be implemented as a therapeutic tool in a gerontopsychiatric ward to reduce symptoms of agitation in patients with dementia. The study was registered in the German Clinical Trials Register (DRKS00024093).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here